Company Filing History:
Years Active: 2019-2023
Title: Filip S Ekholm: Innovator in Glycoprotein and Toxic Payload Conjugates
Introduction
Filip S Ekholm is a notable inventor based in Porvoo, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of glycoprotein and toxic payload conjugates. With a total of 5 patents to his name, Ekholm's work has the potential to impact pharmaceutical compositions and cancer treatment methodologies.
Latest Patents
One of his latest patents is titled "Conjugates of a glycoprotein or a glycan with a toxic payload." This invention relates to a glycoprotein-toxic payload molecule conjugate, a toxic payload molecule-glycan conjugate, and a pharmaceutical composition. The patent also describes methods for preparing the glycoprotein-toxic payload molecule conjugate, modulating the growth of a cell population, and treating tumor cells. Another significant patent is "Saccharide derivative of a toxic payload and antibody conjugates thereof." This patent discloses a molecule comprising a saccharide bound via an O-glycosidic bond to a hydroxyl group of a toxic payload molecule. It further details an antibody-drug conjugate that includes an antibody covalently bound to a toxic payload molecule, optionally via a linker group, along with a saccharide bound to the toxic payload molecule.
Career Highlights
Throughout his career, Filip S Ekholm has worked with several companies, including Glykos Finland Oy and Tenboron Oy. His experience in these organizations has allowed him to refine his expertise in biotechnology and patent development.
Collaborations
Ekholm has collaborated with notable professionals in his field, including Jari Helin and Tero Satomaa. These collaborations have likely contributed to the innovative nature of his patents and advancements in his research.
Conclusion
Filip S Ekholm is a distinguished inventor whose work in glycoprotein and toxic payload conjugates is paving the way for advancements in pharmaceutical applications. His contributions are significant in the ongoing fight against cancer and other diseases.